跳转至内容
Merck
CN
  • Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds.

Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds.

Journal of medicinal chemistry (2012-02-22)
Zengye Hou, Isao Nakanishi, Takayoshi Kinoshita, Yoshinori Takei, Misato Yasue, Ryosuke Misu, Yamato Suzuki, Shinya Nakamura, Tatsuhide Kure, Hiroaki Ohno, Katsumi Murata, Kazuo Kitaura, Akira Hirasawa, Gozoh Tsujimoto, Shinya Oishi, Nobutaka Fujii
摘要

Protein kinase CK2 (CK2) is a ubiquitous serine/threonine protein kinase for hundreds of endogenous substrates. CK2 has been considered to be involved in many diseases, including cancers. Herein we report the discovery of a novel ATP-competitive CK2 inhibitor. Virtual screening of a compound library led to the identification of a hit 2-phenyl-1,3,4-thiadiazole compound. Subsequent structural optimization resulted in the identification of a promising 4-(thiazol-5-yl)benzoic acid derivative.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
腺苷5′-(β,γ-酰亚胺)三磷酸盐 锂盐 水合物, ≥93% (HPLC), powder